Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study.

De Tursi M, Carella C, Tomao S, Cinieri S, Lorusso V, Marchetti P, Vecchio S, Sansoni E, Contu A, Adamo V, Silvestris N, Nuzzo A, Rosti G, Ravaioli A, Danova M, Tonini G, Passalacqua R, Cruciani G, Faedi M, Spada M, De Laurentiis M, Amoroso D, Tomao F, Sperduti I, Grassadonia A, Tinari N, Natoli C, Iacobelli S; Consorzio Interuniversitario Nazionale per la Bio-Oncologia.

Tumori. 2014 Nov-Dec;100(6):e309-13. doi: 10.1700/1778.19310.

PMID:
25688518
2.

Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.

Visani M, de Biase D, Marucci G, Cerasoli S, Nigrisoli E, Bacchi Reggiani ML, Albani F, Baruzzi A, Pession A; PERNO study group.

Mol Oncol. 2014 Mar;8(2):417-30. doi: 10.1016/j.molonc.2013.12.010. Epub 2013 Dec 24.

3.

Benefit from anthracyclines in relation to biological profiles in early breast cancer.

Rocca A, Bravaccini S, Scarpi E, Mangia A, Petroni S, Puccetti M, Medri L, Serra L, Ricci M, Cerasoli S, Biglia N, Maltoni R, Giunchi DC, Gianni L, Tienghi A, Brandi M, Faedi M, Sismondi P, Paradiso A, Silvestrini R, Amadori D.

Breast Cancer Res Treat. 2014 Apr;144(2):307-18. doi: 10.1007/s10549-013-2819-0. Epub 2014 Jan 1. Erratum in: Breast Cancer Res Treat. 2014 Apr;144(2):319. Faedi, Monica [corrected to Faedi, Marina].

PMID:
24381054
4.

Epilepsy in primary cerebral tumors: the characteristics of epilepsy at the onset (results from the PERNO study--Project of Emilia Romagna Region on Neuro-Oncology).

Michelucci R, Pasini E, Meletti S, Fallica E, Rizzi R, Florindo I, Chiari A, Monetti C, Cremonini AM, Forlivesi S, Albani F, Baruzzi A; PERNO Study Group.

Epilepsia. 2013 Oct;54 Suppl 7:86-91. doi: 10.1111/epi.12314. Review.

PMID:
24099060
5.

Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy.

Foca F, Mancini S, Bucchi L, Puliti D, Zappa M, Naldoni C, Falcini F, Gambino ML, Piffer S, Sanoja Gonzalez ME, Stracci F, Zorzi M, Paci E; IMPACT Working Group.

Cancer. 2013 Jun 1;119(11):2022-8. doi: 10.1002/cncr.28014. Epub 2013 Mar 15.

6.

Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference.

Visani M, de Biase D, Marucci G, Taccioli C, Baruzzi A, Pession A; PERNO Study Group.

PLoS One. 2013;8(1):e55314. doi: 10.1371/journal.pone.0055314. Epub 2013 Jan 29.

7.

Trastuzumab-induced cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and protective factors.

Farolfi A, Melegari E, Aquilina M, Scarpi E, Ibrahim T, Maltoni R, Sarti S, Cecconetto L, Pietri E, Ferrario C, Fedeli A, Faedi M, Nanni O, Frassineti GL, Amadori D, Rocca A.

Heart. 2013 May;99(9):634-9. doi: 10.1136/heartjnl-2012-303151. Epub 2013 Jan 24.

PMID:
23349345
8.

LOH 19q indicates shorter disease progression-free interval in low-grade oligodendrogliomas with EMP3 methylation.

Pasini A, Iorio P, Bianchi E, Cerasoli S, Cremonini AM, Faedi M, Guarnieri C, Guiducci G, Riccioni L, Molinari C, Rengucci C, Calistri D, Giordano E.

Oncol Rep. 2012 Dec;28(6):2271-7. doi: 10.3892/or.2012.2047. Epub 2012 Sep 20.

PMID:
22992787
9.

miRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time pCR.

de Biase D, Visani M, Morandi L, Marucci G, Taccioli C, Cerasoli S, Baruzzi A, Pession A; PERNO Study Group.

PLoS One. 2012;7(4):e35596. doi: 10.1371/journal.pone.0035596. Epub 2012 Apr 18.

10.

Epidemiological changes in breast tumours in Italy: the IMPACT study on mammographic screening programmes.

IMPACT WORKING Group.

Pathologica. 2011 Oct;103(5):290-3. No abstract available.

PMID:
22393684
11.

Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.

Agnelli G, George DJ, Kakkar AK, Fisher W, Lassen MR, Mismetti P, Mouret P, Chaudhari U, Lawson F, Turpie AG; SAVE-ONCO Investigators.

N Engl J Med. 2012 Feb 16;366(7):601-9. doi: 10.1056/NEJMoa1108898.

12.

Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer.

Amadori D, Silvestrini R, De Lena M, Boccardo F, Rocca A, Scarpi E, Schittulli F, Brandi M, Maltoni R, Serra P, Ponzone R, Biglia N, Gianni L, Tienghi A, Valerio MR, Bonginelli P, Amaducci L, Faedi M, Baldini E, Paradiso A.

Breast Cancer Res Treat. 2011 Feb;125(3):775-84. doi: 10.1007/s10549-010-1257-5. Epub 2010 Dec 4.

PMID:
21132360
13.

Epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil versus paclitaxel followed by epirubicin and vinorelbine in patients with high-risk operable breast cancer.

Boccardo F, Amadori D, Guglielmini P, Sismondi P, Farris A, Agostara B, Gambi A, Catalano G, Faedi M, Rubagotti A.

Oncology. 2010;78(3-4):274-81. doi: 10.1159/000315735. Epub 2010 Jun 8.

PMID:
20530973
14.

Chromosome 1p and 19q evaluation in low-grade oligodendrogliomas: a descriptive study.

Molinari C, Iorio P, Medri L, Ballardini M, Guiducci G, Cremonini AM, Cerasoli S, Riccioni L, Faedi M, Mariani GA, Zoli W, Silvestrini R, Calistri D.

Int J Mol Med. 2010 Jan;25(1):145-51.

PMID:
19956913
15.

Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

Brandes AA, Tosoni A, Franceschi E, Blatt V, Santoro A, Faedi M, Amistà P, Gardiman M, Labianca R, Bianchini C, Ermani M, Reni M.

Cancer Chemother Pharmacol. 2009 Sep;64(4):769-75. doi: 10.1007/s00280-009-0926-8. Epub 2009 Jan 24.

16.

Temozolomide as salvage treatment in primary brain lymphomas.

Reni M, Zaja F, Mason W, Perry J, Mazza E, Spina M, Bordonaro R, Ilariucci F, Faedi M, Corazzelli G, Manno P, Franceschi E, Pace A, Candela M, Abbadessa A, Stelitano C, Latte G, Ferreri AJ.

Br J Cancer. 2007 Mar 26;96(6):864-7. Epub 2007 Feb 27.

17.

Primary gastric lymphoma: a review of 45 cases.

Ravaioli A, Amadori M, Faedi M, Rosti G, Folli S, Barbieri C, Giorgini G, Marangolo M, Emiliani E, Amadori D.

Eur J Cancer Clin Oncol. 1986 Dec;22(12):1461-5.

PMID:
3595671
18.

Chemotherapy of advanced gastric cancer: a study of 43 consecutive cases treated with fluorouracil, adriamycin and mitomycin C (FAM).

Faedi M, Amadori M, Gentilini P, Ridolfi R, Ravaioli A, Amadori D, Biserni R, Bonaguri C.

Chemioterapia. 1986 Aug;5(4):240-3.

PMID:
3769045
19.

Prognostic significance of large mediastinal involvement in Hodgkin's disease.

Mazza P, Lauria F, Sciascia R, Emiliani E, Fiacchini M, Baccarani M, Frezza G, Dominici G, Cantore M, Faedi M, et al.

Scand J Haematol. 1983 Oct;31(4):315-21.

PMID:
6688679
20.

[Testicular lymphoma in a 72-year-old patient].

Mazza P, Faedi M, Cantore M.

Haematologica. 1982 Oct;67(5):809. Italian. No abstract available.

PMID:
6816696
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk